Gait assessment in Parkinson's disease patients through a network of wearable accelerometers in unsupervised environments

Parkinson's disease (PD) predominantly alters the motor performance of the affected individuals. In particular, the loss of dopaminergic neurons compromises the speed, the automaticity and fluidity of movements. As the disease evolves, PD patient's motion becomes slower and tremoric and the response to medication fluctuates along the day. In addition, the presence of involuntary movements deteriorates voluntary movement in advanced state of the disease. These changes in the motion can be detected by studying the variation of the signals recorded by accelerometers attached in the limbs and belt of the patients. The analysis of the most significant changes in these signals make possible to build an individualized motor profile of the disease, allowing doctors to personalize the medication intakes and consequently improving the response of the patient to the treatment. Several works have been done in a laboratory and supervised environments providing solid results; this work focused on the design of unsupervised method for the assessment of gait in PD patients. The development of a reliable quantitative tool for long-term monitoring of PD symptoms would allow the accurate detection of the clinical status during the different PD stages and the evaluation of motor complications. Besides, it would be very useful both for routine clinical care as well as for novel therapies testing.

[1]  Ann Ashburn,et al.  A meta‐analysis of six prospective studies of falling in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[2]  J Losy,et al.  [Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cytokines in amyotrophic lateral sclerosis]. , 2001, Neurologia i neurochirurgia polska.

[3]  N Giladi,et al.  Paroxysmal locomotion gait disturbances in Parkinson's disease. , 2001, Neurologia i neurochirurgia polska.

[4]  J. Richman,et al.  Physiological time-series analysis using approximate entropy and sample entropy. , 2000, American journal of physiology. Heart and circulatory physiology.

[5]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[6]  Catherine Dehollain,et al.  Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring , 2004, IEEE Transactions on Biomedical Engineering.

[7]  Jeffrey M. Hausdorff,et al.  Falls in outpatients with Parkinson's disease , 2005, Journal of Neurology.

[8]  J. Summers,et al.  The pathogenesis of gait hypokinesia in Parkinson's disease. , 1994, Brain : a journal of neurology.

[9]  Jeffrey M. Hausdorff,et al.  Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena , 2004, Movement disorders : official journal of the Movement Disorder Society.

[10]  D. Alvarez,et al.  Comparison of Step Length Estimators from Weareable Accelerometer Devices , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[11]  A. Zwinderman,et al.  Prospective assessment of falls in Parkinson's disease , 2001, Journal of Neurology.

[12]  Jeffrey M. Hausdorff,et al.  Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. , 2005, Journal of neurology.

[13]  P. Gray,et al.  Fall Risk Factors in Parkinson's Disease , 2000, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[14]  Jeffrey M. Hausdorff,et al.  Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease , 2006, The European journal of neuroscience.

[15]  Jorge Cancela,et al.  Multi-parametric system for the continuous assessment and monitoring of motor status in Parkinson's disease: An entropy-based gait comparison , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.